|
| 37643903 | Impact of Risk Factors on COVID-19 Outcomes in Unvaccinated People With Rheumatic Diseases: A Comparative Analysis of Pandemic Epochs Using the COVID-19 Global Rheumatology Alliance Registry. | Arthritis Care Res (Hoboken) | 2024 |
| 37839812 | Breakthrough COVID-19 After Tixagevimab/Cilgavimab Among Patients With Systemic Autoimmune Rheumatic Diseases. | J Rheumatol | 2024 |
| 37643919 | Incidence of Pneumocystis Jiroveci Pneumonia in Patients With ANCA-Associated Vasculitis Initiating Therapy With Rituximab or Cyclophosphamide. | Arthritis Care Res (Hoboken) | 2024 |
| 34426400 | Response to: Correspondence on "Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global Rheumatology Alliance physician registry" by Sparks <i>et al</i>. | Ann Rheum Dis | 2023 |
| 37597102 | Considerations for Pharmacologic Management of Rheumatoid Arthritis in the COVID-19 Era: a Narrative Review. | Curr Rheumatol Rep | 2023 |
| 38019932 | T cell responses to SARS-CoV-2 infection and vaccination are elevated in B cell deficiency and reduce risk of severe COVID-19. | Sci Transl Med | 2023 |
| 37913612 | Risk factors and outcomes for repeat COVID-19 infection among patients with systemic autoimmune rheumatic diseases: A case-control study. | Semin Arthritis Rheum | 2023 |
| 38070152 | Associations of DMARDs with post-acute sequelae of COVID-19 in patients with systemic autoimmune rheumatic diseases: a prospective study. | Rheumatology (Oxford) | 2023 |
| 37956428 | SARS-CoV-2 Virologic Rebound With Nirmatrelvir-Ritonavir Therapy : An Observational Study. | Ann Intern Med | 2023 |
| 37520279 | Omicron variant infection in inflammatory rheumatological conditions - outcomes from a COVID-19 naive population in Aotearoa New Zealand. | Lancet Reg Health West Pac | 2023 |
| 37619485 | Assessment of patient-reported symptoms and distress in IgG4-related disease (IgG4-RD): Development, clinical validation, and content validation of the IgG4-RD Symptom Severity Index. | Semin Arthritis Rheum | 2023 |
| 38048611 | Rheumatoid arthritis, quantitative parenchymal lung features, and mortality among smokers. | Rheumatology (Oxford) | 2023 |
| 37577493 | SARS-CoV-2 Viral Clearance and Evolution Varies by Extent of Immunodeficiency. | medRxiv | 2023 |
| 37873462 | Immunomodulators and risk for breakthrough infection after third COVID-19 mRNA vaccine among patients with rheumatoid arthritis: A cohort study. | medRxiv | 2023 |
| 37672567 | Humoral immunity to an endemic coronavirus is associated with postacute sequelae of COVID-19 in individuals with rheumatic diseases. | Sci Transl Med | 2023 |
| 35699465 | Interstitial lung disease in ANCA-associated vasculitis: associated factors, radiographic features and mortality. | Rheumatology (Oxford) | 2023 |
| 37425934 | SARS-CoV-2 virologic rebound with nirmatrelvir-ritonavir therapy. | medRxiv | 2023 |
| 37192270 | Weighing the Risks and Benefits of Pneumocystis Jirovecii Pneumonia Prophylaxis in Rituximab Users. | Arthritis Rheumatol | 2023 |
| 37457635 | An Unexpected Case of Cutaneous Vasculitis Following Zoledronic Acid Infusion. | JCEM Case Rep | 2023 |
| 37054986 | US National Institutes of Health Prioritization of SARS-CoV-2 Variants. | Emerg Infect Dis | 2023 |
| 37011036 | Comparative Effectiveness of Rituximab- Versus Cyclophosphamide-Based Remission Induction Strategies in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis for the Risk of Kidney Failure and Mortality. | Arthritis Rheumatol | 2023 |
| 37137671 | Incidence, prevalence and mortality of IgG4-related disease in the USA: a claims-based analysis of commercially insured adults. | Ann Rheum Dis | 2023 |
| 37331741 | Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 2019. | Rheum Dis Clin North Am | 2023 |
| 36889799 | Risk of COVID-19 among unvaccinated and vaccinated patients with systemic lupus erythematosus: a general population study. | RMD Open | 2023 |
| 36856264 | Longitudinal Patterns of Renal Function in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. | Arthritis Care Res (Hoboken) | 2023 |
| 36787993 | Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries. | Ann Rheum Dis | 2023 |
| 36752280 | Acute and postacute COVID-19 outcomes for patients with rheumatoid arthritis: lessons learned and emerging directions 3 years into the pandemic. | Curr Opin Rheumatol | 2023 |
| 36855108 | Comparative effectiveness of BNT162b2 and ChAdOx1 nCoV-19 vaccines against COVID-19. | BMC Med | 2023 |
| 36442978 | Impact of vaccination on postacute sequelae of SARS CoV-2 infection in patients with rheumatic diseases. | Ann Rheum Dis | 2023 |
| 36848823 | IgG4-related disease as a variable-vessel vasculitis: A case series of 13 patients with medium-sized coronary artery involvement. | Semin Arthritis Rheum | 2023 |
| 36649456 | Association Between Systemic Vasculitis and Coronary Microvascular Dysfunction in the Absence of Obstructive Coronary Artery Disease. | Circ Cardiovasc Imaging | 2023 |
| 36844970 | Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort study. | Lancet Rheumatol | 2023 |
| 36645017 | Development and Validation of a Simulation Model for Treatment to Maintain Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. | Arthritis Care Res (Hoboken) | 2023 |
| 36642428 | Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines Against COVID-19 Infection Among Patients With Systemic Autoimmune Rheumatic Diseases on Immunomodulatory Medications. | J Rheumatol | 2023 |
| 36239292 | Association Between Race/Ethnicity and COVID-19 Outcomes in Systemic Lupus Erythematosus Patients From the United States: Data From the COVID-19 Global Rheumatology Alliance. | Arthritis Care Res (Hoboken) | 2023 |
| 36124987 | Obstetric outcomes in women with rheumatic disease and COVID-19 in the context of vaccination status. | Rheumatology (Oxford) | 2023 |
| 36161711 | Risk of COVID-19 Among Unvaccinated and Vaccinated Patients With Rheumatoid Arthritis: A General Population Study. | Arthritis Care Res (Hoboken) | 2023 |
| 36347211 | Factors associated with COVID-19 breakthrough infection among vaccinated patients with rheumatic diseases: A cohort study. | Semin Arthritis Rheum | 2023 |
| 36319016 | The Positive Predictive Value of a Very High Serum IgG4 Concentration for the Diagnosis of IgG4-Related Disease. | J Rheumatol | 2023 |
| 36082457 | Gout and Excess Risk of Severe SARS-CoV-2 Infection Among Vaccinated Individuals: A General Population Study. | Arthritis Rheumatol | 2023 |
| 33692020 | Response to: 'Correspondence on 'SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease'' by C et al. | Ann Rheum Dis | 2023 |
| 35313091 | Assessing the Severity of COVID-19 Lung Injury in Rheumatic Diseases Versus the General Population Using Deep Learning-Derived Chest Radiograph Scores. | Arthritis Care Res (Hoboken) | 2023 |
| 32586919 | Response to: 'Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors' by Jovani et al. | Ann Rheum Dis | 2022 |
| 35617780 | DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study. | Semin Arthritis Rheum | 2022 |
| 35442573 | COVID-19 Surveillance Testing in Secondary Schools: Findings and Barriers to Implementation. | WMJ | 2022 |
| 35441152 | Effectiveness of COVID-19 vaccination in immune-mediated inflammatory diseases. | Lancet Rheumatol | 2022 |
| 35797765 | Risk of gout flares after COVID-19 vaccination: A case-crossover study. | Semin Arthritis Rheum | 2022 |
| 35765565 | Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: From the first wave to Omicron. | medRxiv | 2022 |
| 35669677 | Experience with telemedicine among rheumatology clinicians during the COVID-19 pandemic: an international survey. | Rheumatol Adv Pract | 2022 |
| 35697489 | The effect of achieving serological remission on subsequent risk of relapse, end-stage renal disease and mortality in ANCA-associated vasculitis: a target trial emulation study. | Ann Rheum Dis | 2022 |